Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Modeling of Methadone in Opioid Addiction
NCT05490732Recruiting
- Sponsor
- CHU Montpellier
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of methadone in opioid use disorder (OUD), sponsored by CHU Montpellier. Primary endpoint: Peak concentration at 18 months. Started Mar 2024; status: recruiting.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05490732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05490732.